urea has been researched along with carboplatin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koksál, J; Kvĕtina, J; Láznícek, M; Láznícková, A; Semecký, V; Zubr, V | 1 |
| Lelieveld, P; van der Vijgh, WJ; van Velzen, D | 1 |
| Harrap, KR | 1 |
| Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A | 1 |
| Cohen, RB; Cosgriff, TM; Eisenberg, PD; Hainsworth, JD; Healey, D; Langer, CJ; Liau, K; Madajewicz, S; Pierce, K; Simon, GR; Xu, H | 1 |
2 trial(s) available for urea and carboplatin
| Article | Year |
|---|---|
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine | 2007 |
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Exanthema; Female; Gastrointestinal Diseases; Half-Life; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Thiazoles; Treatment Outcome; Urea | 2007 |
3 other study(ies) available for urea and carboplatin
| Article | Year |
|---|---|
Effect of oxoplatinum and CBDCA on renal functions in rats.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Creatinine; Glomerular Filtration Rate; Kidney; Male; Organoplatinum Compounds; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Urea | 1989 |
Preclinical toxicology of platinum analogues in dogs.
Topics: Animals; Body Weight; Carboplatin; Cisplatin; Creatinine; Dogs; Dose-Response Relationship, Drug; Kidney Diseases; Leukocyte Count; Male; Organoplatinum Compounds; Platelet Count; Proteinuria; Urea; Vomiting | 1987 |
Preclinical studies identifying carboplatin as a viable cisplatin alternative.
Topics: Animals; Antineoplastic Agents; Blood; Body Weight; Carboplatin; Cisplatin; Drug Evaluation, Preclinical; Kidney; Mice; Neoplasms, Experimental; Nucleoproteins; Organoplatinum Compounds; Phosphorylation; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Urea | 1985 |